Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nicholls

Showing results (1101-1110 of 1,396) with videos related to

Pageof 140
Sort By:
European Heart Journal|July 27, 2013
Coronary atheroma volume and cardiovascular events during maximally intensive statin therapyRishi Puri, Steven E Nissen, Mingyuan Shao, et al.
JAMA Cardiology|July 9, 2020
Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE TrialRishi Puri, Steven E Nissen, Benoit J Arsenault, et al.
Journal of the American Heart Association|November 23, 2019
Plasma Aldosterone Levels Are Not Associated With Cardiovascular Events Among Patients With High-Risk Vascular Disease: Insights From the ACCELERATE TrialAnirudh Kumar, Divyang R Patel, Danielle M Brennan, et al.
Cardiovascular Diabetology|June 23, 2021
Relation of insulin treatment for type 2 diabetes to the risk of major adverse cardiovascular events after acute coronary syndrome: an analysis of the BETonMACE randomized clinical trialGregory G Schwartz, Stephen J Nicholls, Peter P Toth, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 16, 2014
Coronary artery wall shear stress is associated with endothelial dysfunction and expansive arterial remodelling in patients with coronary artery diseaseRishi Puri, Darryl P Leong, Stephen J Nicholls, et al.
JAMA Cardiology|March 12, 2018
ADCY9 Genetic Variants and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease: A Nested Case-Control StudySteven E Nissen, Sreekumar G Pillai, Stephen J Nicholls, et al.
Heart Rhythm O2|December 8, 2025
Cardiac resynchronization therapy and AV node ablation in heart failure with reduced ejection fraction and atrial fibrillation: Rationale and design of the CAAN-AF trialPrashanthan Sanders, Jonathan P Ariyaratnam, Alexis Puvrez, et al.
CJC Open|September 26, 2025
Circulating Angiopoietin-Like Protein 3 Level and Plaque Calcification: An Optical Coherence Tomography Imaging AnalysisYu Kataoka, Kota Murai, Stephen J Nicholls, et al.
Regional Environmental Change|February 9, 2026
Relative importance of climate versus socio-environmental development changes to 2050 in rural coastal Bangladesh-a system analysisAttila N Lázár, Robert J Nicholls, Craig W Hutton, et al.
International Journal of Molecular Sciences|March 28, 2024
TRIM2 Selectively Regulates Inflammation-Driven Pathological Angiogenesis without Affecting Physiological Hypoxia-Mediated AngiogenesisNathan K P Wong, Emma L Solly, Richard Le, et al.
Pageof 140

Showing results (1101-1110 of 1,396) with videos related to

Sort By:
Pageof 140
European Heart Journal|July 27, 2013
Coronary atheroma volume and cardiovascular events during maximally intensive statin therapyRishi Puri, Steven E Nissen, Mingyuan Shao, et al.
JAMA Cardiology|July 9, 2020
Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE TrialRishi Puri, Steven E Nissen, Benoit J Arsenault, et al.
Journal of the American Heart Association|November 23, 2019
Plasma Aldosterone Levels Are Not Associated With Cardiovascular Events Among Patients With High-Risk Vascular Disease: Insights From the ACCELERATE TrialAnirudh Kumar, Divyang R Patel, Danielle M Brennan, et al.
Cardiovascular Diabetology|June 23, 2021
Relation of insulin treatment for type 2 diabetes to the risk of major adverse cardiovascular events after acute coronary syndrome: an analysis of the BETonMACE randomized clinical trialGregory G Schwartz, Stephen J Nicholls, Peter P Toth, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 16, 2014
Coronary artery wall shear stress is associated with endothelial dysfunction and expansive arterial remodelling in patients with coronary artery diseaseRishi Puri, Darryl P Leong, Stephen J Nicholls, et al.
JAMA Cardiology|March 12, 2018
ADCY9 Genetic Variants and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease: A Nested Case-Control StudySteven E Nissen, Sreekumar G Pillai, Stephen J Nicholls, et al.
Heart Rhythm O2|December 8, 2025
Cardiac resynchronization therapy and AV node ablation in heart failure with reduced ejection fraction and atrial fibrillation: Rationale and design of the CAAN-AF trialPrashanthan Sanders, Jonathan P Ariyaratnam, Alexis Puvrez, et al.
CJC Open|September 26, 2025
Circulating Angiopoietin-Like Protein 3 Level and Plaque Calcification: An Optical Coherence Tomography Imaging AnalysisYu Kataoka, Kota Murai, Stephen J Nicholls, et al.
Regional Environmental Change|February 9, 2026
Relative importance of climate versus socio-environmental development changes to 2050 in rural coastal Bangladesh-a system analysisAttila N Lázár, Robert J Nicholls, Craig W Hutton, et al.
International Journal of Molecular Sciences|March 28, 2024
TRIM2 Selectively Regulates Inflammation-Driven Pathological Angiogenesis without Affecting Physiological Hypoxia-Mediated AngiogenesisNathan K P Wong, Emma L Solly, Richard Le, et al.
Pageof 140